SCHEMBL24915570

SCHEMBL24915570

COc1cc(C(=O)Nc2ncco2)c2nc(C)cc(C(C)C)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
CSNK2A3 Q8NEV1 1/20 0.39
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 2/20 0.36
LRRK2 Q5S007 1/20 0.35
DHODH Q02127 1/20 0.35
PSMD14 O00487 1/20 0.35
STAMBP O95630 1/20 0.35
COPS5 Q92905 1/20 0.35
CYP3A4 P08684 1/20 0.35
PDE10A Q9Y233 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
FFAR2 O15552 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915568 0.83 KDM4E (0.36) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL24915921 0.81 MTNR1A (0.43) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL29923203 0.80 PSMD14 (0.42) CSNK2A2CSNK2BCSNK2A1CSNK2A3KDM4E
SCHEMBL24915560 0.77 PIK3CA (0.50) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL24916230 0.77 SCN9A (0.36) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL24916058 0.77 KDM4E (0.50) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL24915923 0.76 CD38 (0.45) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL24915919 0.75 HPGD (0.43) KDM4EALDH1A1CYP3A4NPC1RAB9A
SCHEMBL24915854 0.69 MTNR1A (0.43) KDM4EALDH1A1HPGDEGLN1MEN1
SCHEMBL24915856 0.69 JAK2 (0.42) KDM4EALDH1A1NPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 CSNK2A2 1031/4885CSNK2B 1054/4885CSNK2A1 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.